Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
Q3 2023 vs. Q2 2023
How the institutions holding Cero Therapeutics Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 10 | −3 |
| Shares | 1.13M | 830.1K | −301.4K (−26.6%) |
| Value | $10.6M | $7.33M | −$3.28M (−30.9%) |
New holders (1)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shaolin Capital Management LLC | 50,000 | $543.0K | 0.02% |
Sold out (4)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Polar Asset Management Partners Inc. | 120,000 | $1.29M |
| CNH Partners LLC | 79,873 | $862.6K |
| FNY Investment Advisers, LLC | 2,084 | $22.0K |
| Tower Research Capital LLC (TRC) | 6 | $65 |